interest in perindopril (Coversyl) and other ACE inhibitors for patients with coronary heart disease
October 2003
You'll see more interest in perindopril (Coversyl) and other ACE inhibitors for patients with coronary heart disease.
This trend started a few years ago when the huge "HOPE" trial brought to light the benefits of ramipril (Altace) for heart disease...even in patients who DON'T have hypertension or heart failure.
Now we know that perindopril has similar benefits. It reduces the risk of heart attacks and cardiovascular death in patients with coronary heart disease.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive